Selective antagonism of opioid analgesia by a sigma system - PubMed (original) (raw)
. 1994 Dec;271(3):1583-90.
Affiliations
- PMID: 7996472
Selective antagonism of opioid analgesia by a sigma system
C C Chien et al. J Pharmacol Exp Ther. 1994 Dec.
Abstract
(+)Pentazocine antagonizes morphine analgesia as potently as its (-)-isomer, ruling out an opioid receptor mechanism of action and suggesting, which suggests a role for sigma 1 receptors. Systemic (+) pentazocine also reverses supraspinal or spinal morphine analgesia. 1,3-Di(2-tolyl)guanidine, a sigma ligand with no appreciable opioid receptor affinity, antagonizes morphine analgesia. The actions of both (+)pentazocine and 1,3-di(2-tolyl)guanidine are reversed by haloperidol, which has high affinity for both sigma and D2 receptors, but not by the D2-selective antagonist (-)sulpiride, which lacks activity at sigma sites. The antiopioid sigma system is tonically active. Haloperidol, but not (-)sulpiride, decreases morphine ED50 almost 2-fold. The antiopioid system modulates only mu analgesia. Unlike analgesia, (+)pentazocine does not influence morphine's inhibition of gastrointestinal transit or lethality. (+)Pentazocine also antagonizes kappa 1, kappa 3 and delta analgesia through sigma mechanisms in a haloperidol-sensitive manner. (-)Sulpiride is inactive. Alone, haloperidol enhances kappa 1, kappa 3 and delta analgesia more dramatically than morphine, which indicates that the sigma system is active against all opioid analgesic systems. Sigma systems are responsible for some strain differences in kappa receptor sensitivity. Unlike CD-1 mice, BALB-C mice are relatively insensitive toward the kappa 1 agent U50,488H and the kappa 3 analgesic naloxone benzoylhydrazone. Blockade of the sigma system with haloperidol eliminates these strain differences. In conclusion, sigma 1 systems functionally antagonize opioid analgesia without affecting morphine's effects on gastrointestinal transit or lethality. The antiopioid sigma system is tonically active and is more active against kappa analgesia than mu.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA, Paul D, Hahn EF, Pasternak GW. Gistrak MA, et al. J Pharmacol Exp Ther. 1989 Nov;251(2):469-76. J Pharmacol Exp Ther. 1989. PMID: 2553921 - Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Porreca F, et al. J Pharmacol Exp Ther. 1984 Aug;230(2):341-8. J Pharmacol Exp Ther. 1984. PMID: 6086883 - Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE, Lemcke PK, Gehrig CA, Hruby VJ, Burks TF. Shook JE, et al. J Pharmacol Exp Ther. 1989 Apr;249(1):83-90. J Pharmacol Exp Ther. 1989. PMID: 2540324 - [Possible role of sigma-receptors in the regulation of cough reflex, gastrointestinal and retinal function].
Kamei J. Kamei J. Nihon Yakurigaku Zasshi. 1999 Jul;114(1):35-41. doi: 10.1254/fpj.114.35. Nihon Yakurigaku Zasshi. 1999. PMID: 10562963 Review. Japanese. - Narcotic analgesics, their detection and pain measurement in the horse: a review.
Kamerling S, Wood T, DeQuick D, Weckman TJ, Tai C, Blake JW, Tobin T. Kamerling S, et al. Equine Vet J. 1989 Jan;21(1):4-12. doi: 10.1111/j.2042-3306.1989.tb02081.x. Equine Vet J. 1989. PMID: 2563969 Review.
Cited by
- Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
Romero L, Zamanillo D, Nadal X, Sánchez-Arroyos R, Rivera-Arconada I, Dordal A, Montero A, Muro A, Bura A, Segalés C, Laloya M, Hernández E, Portillo-Salido E, Escriche M, Codony X, Encina G, Burgueño J, Merlos M, Baeyens JM, Giraldo J, López-García JA, Maldonado R, Plata-Salamán CR, Vela JM. Romero L, et al. Br J Pharmacol. 2012 Aug;166(8):2289-306. doi: 10.1111/j.1476-5381.2012.01942.x. Br J Pharmacol. 2012. PMID: 22404321 Free PMC article. - Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids.
Vidal-Torres A, Fernández-Pastor B, García M, Ayet E, Cabot A, Burgueño J, Monroy X, Aubel B, Codony X, Romero L, Pascual R, Serafini MT, Encina G, Almansa C, Zamanillo D, Merlos M, Vela JM. Vidal-Torres A, et al. Acta Pharm Sin B. 2023 Jan;13(1):82-99. doi: 10.1016/j.apsb.2022.09.018. Epub 2022 Sep 25. Acta Pharm Sin B. 2023. PMID: 36815042 Free PMC article. - miRNome Expression Analysis Reveals New Players on Leprosy Immune Physiopathology.
Salgado CG, Pinto P, Bouth RC, Gobbo AR, Messias ACC, Sandoval TV, Dos Santos AMR, Moreira FC, Vidal AF, Goulart LR, Barreto JG, da Silva MB, Frade MAC, Spencer JS, Santos S, Ribeiro-Dos-Santos Â. Salgado CG, et al. Front Immunol. 2018 Mar 9;9:463. doi: 10.3389/fimmu.2018.00463. eCollection 2018. Front Immunol. 2018. PMID: 29593724 Free PMC article. Clinical Trial. - The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems.
Su TP, Su TC, Nakamura Y, Tsai SY. Su TP, et al. Trends Pharmacol Sci. 2016 Apr;37(4):262-278. doi: 10.1016/j.tips.2016.01.003. Epub 2016 Feb 9. Trends Pharmacol Sci. 2016. PMID: 26869505 Free PMC article. Review. - dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat.
Wu HE, Schwasinger ET, Terashvili M, Tseng LF. Wu HE, et al. Eur J Pharmacol. 2007 May 21;562(3):221-6. doi: 10.1016/j.ejphar.2007.01.083. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17335800 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials